心臓ポンプ装置の世界市場予測 2022年：補助人工心臓 (VAD)・大動脈内バルーンポンプ・完全人工心臓 (TAH)・BTC・BTT・DT
Heart Pump Device Market by Product (Ventricular Assist Device (LVAD, RVAD, BiVAD, and pVAD), Intra Aortic Balloon Pump, TAH), Type (Extracorporeal and Implantable Pump), Therapy (Bridge-to-transplant, Destination Therapy) - Global Forecast to 2022
|出版日||ページ情報||英文 132 Pages
|心臓ポンプ装置の世界市場予測 2022年：補助人工心臓 (VAD)・大動脈内バルーンポンプ・完全人工心臓 (TAH)・BTC・BTT・DT Heart Pump Device Market by Product (Ventricular Assist Device (LVAD, RVAD, BiVAD, and pVAD), Intra Aortic Balloon Pump, TAH), Type (Extracorporeal and Implantable Pump), Therapy (Bridge-to-transplant, Destination Therapy) - Global Forecast to 2022|
|出版日: 2018年05月10日||ページ情報: 英文 132 Pages||
世界の心臓ポンプ装置市場は、2017年の16億4,000万米ドルから、2022年までに39億8,000万米ドルへ拡大すると予測され、予測期間のCAGR (複合年間成長率) は19.4%が見込まれています。心血管疾患の有病率の増加、規制承認数の増加、およびドナー心臓の需要と供給の大きな格差は、心臓ポンプ装置の需要を促進しています。しかし、代替ドラッグデリバリー方式に対する嗜好、および新興諸国における不十分な医療費償還状況は、予測期間中の同市場の成長を抑制すると予測されています。
The global heart pump devices market is projected to reach USD 3.98 billion by 2022 from an estimated USD 1.64 billion in 2017, at a CAGR of 19.4% during the forecast period. Rising prevalence of cardiovascular diseases, increasing number of regulatory approvals, and a huge gap between the demand and supply of donor hearts is driving the demand for heart pump devices. However, preference for alternative drug delivery modes and poor reimbursement scenario in developing countries is expected to restrain the growth of this market during the forecast period.
Based on product, the market is segmented into ventricular assist devices, intra-aortic balloon pumps, and total artificial heart. The ventricular assist devices market is expected to grow at highest CAGR during the forecast period. This can be attributed to improved safety and efficacy of these devices as a result of technological advancements.
Based on therapy, the global heart pump devices market is segmented into bridge-to-transplant, bridge-to-candidacy, destination therapy, and other therapies such as bridge-to-recovery and rescue therapy. The destination therapy segment is expected to grow at the highest CAGR during the forecast period.
North America is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the North American market is attributed to rising prevalence of cardiovascular diseases, favorable reimbursement scenario, and increasing regulatory approvals in that region.
Break of primary participants was as mentioned below:
The key players in the global heart pump devices market are: St. Jude Medical ( subsidiary of Abbott Laboratories) (US), Abiomed (US), Medtronic (Ireland), Getinge (Sweden), Teleflex (US), ReliantHeart (US), BerlinHeart (Germany), Terumo (Japan), SynCardia Systems (US), TandemLife (CardiacAssist) (US), Jarvik Heart (US), and Fresenius Medical Care (Germany).
The report analyzes the heart pump devices market and aims at estimating the market size and future growth potential of this market based on various segments such as product, type, therapy, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.
This report provides insights into the following pointers:
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.